RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
Xiaomeng Zhang(First Hospital of China Medical University), Yunpeng Liu(First Hospital of China Medical University)
Cited by 8
Related Papers
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis
|BMC Cancer|2011|136
CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
|BMC Cancer|2018|86